Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

IRAA

Iris Acquisition (IRAA)

Iris Acquisition Corporation

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:IRAA

1

Data	Hora	Fonte	Título	Código	Companhia
02/06/2023	17:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IRAA	Iris Acquisition Corporation
15/05/2023	17:07	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:IRAA	Iris Acquisition Corporation
31/03/2023	17:15	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	NASDAQ:IRAA	Iris Acquisition Corporation
23/02/2023	16:25	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:IRAA	Iris Acquisition Corporation
23/02/2023	15:14	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:IRAA	Iris Acquisition Corporation
14/02/2023	11:52	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:IRAA	Iris Acquisition Corporation
30/11/2022	22:46	Business Wire	Liminatus Pharma LLC and Iris Acquisition Corp to combine to incorporate and accelerate much-needed cancer treatments	NASDAQ:IRAA	Iris Acquisition Corporation
23/11/2022	12:00	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (prer14a)	NASDAQ:IRAA	Iris Acquisition Corporation
22/11/2022	18:07	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	NASDAQ:IRAA	Iris Acquisition Corporation
21/11/2022	19:27	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:IRAA	Iris Acquisition Corporation
10/11/2022	09:58	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:IRAA	Iris Acquisition Corporation